Stock Events

Stock Events

XSpray Pharma AB 

SEK59.2
0
+SEK6.4+12.12% Thursday 15:06

Statistics

Day High
59.5
Day Low
52.8
52W High
59.5
52W Low
44.5
Volume
62,758
Avg. Volume
28,410
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

5NovExpected
Q2 2025
Q3 2025
-1.69
-1.52
-1.35
-1.18
Expected EPS
-1.66262027754339
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-285.52MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XSPRAY-BTA.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company's product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has partnership agreements with EVERSANA for the commercialization of Dasynoc, as well as with NerPharMa for commercial production of Dasynoc. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Per Andersson Ph.D.
Employees
24
Country
Sweden
ISIN
SE0026140865

Listings

F
DE
6XP.F
STU
DE
6XP.STU
MU
DE
6XP.MU
LSE
GB
0GHZ.LSE

0 Comments

Share your thoughts

FAQ

What is XSpray Pharma AB stock price today?▼
The current price of XSPRAY-BTA.ST is SEK59.2 SEK — it has increased by +12.12% in the past 24 hours. Watch XSpray Pharma AB stock price performance more closely on the chart.
What is XSpray Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XSpray Pharma AB stocks are traded under the ticker XSPRAY-BTA.ST.
What is XSpray Pharma AB revenue for the last year?▼
XSpray Pharma AB revenue for the last year amounts to 0 SEK.
What is XSpray Pharma AB net income for the last year?▼
XSPRAY-BTA.ST net income for the last year is -285.52M SEK.
How many employees does XSpray Pharma AB have?▼
As of April 15, 2026, the company has 24 employees.
In which sector is XSpray Pharma AB located?▼
XSpray Pharma AB operates in the Other sector.
When did XSpray Pharma AB complete a stock split?▼
XSpray Pharma AB has not had any recent stock splits.
Where is XSpray Pharma AB headquartered?▼
XSpray Pharma AB is headquartered in Solna, Sweden.